Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Celyad Oncology SA (EBR:CYAD)
Belgium
· Delayed Price · Currency is EUR
Watchlist
Compare
0.2980
-0.0110 (-3.56%)
Sep 29, 2025, 5:09 PM CET
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
Dec '18
Dec 31, 2018
2012 - 2017
Cardiology
186.00K
Log In
Log In
Log In
Log In
Upgrade
Cardiology Growth
82.35%
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology
-
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Revenue by Geography
Fiscal year is January - December.
Download
Full Width
Year Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '20
Dec 31, 2020
Dec '19
Dec 31, 2019
Dec '18
Dec 31, 2018
2012 - 2017
Europe and United States
186.00K
Log In
Log In
Log In
Log In
Upgrade
Europe and United States Growth
82.35%
Log In
Log In
Log In
Log In
Upgrade